| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |